Hematologic Neoplasms
📧 Sign up to get email alerts when something new happens for Hematologic Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
This clinical trial update describes the collection of tissue specimens from patients with solid tumors or hematologic neoplasms and their H…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Cognitive Training Intervention and Attitudes Towards Genetics [NA]
Clinical trial update for a University of Alabama at Birmingham study evaluating a cognitive training intervention and attitudes toward gene…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) [NA]
This clinical trial from Technical University of Munich is testing whether large-language model–generated plain-language patient synopses im…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Mind-body Medicine for Patients With Malignant Hematological Diseases [NA]
A clinical trial evaluating mind-body medicine for patients with malignant hematologic diseases is currently recruiting, sponsored by Univer…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies [Phase 1, Phase 2]
Phase I/II clinical trial sponsored by the National Cancer Institute to reduce post-transplant cyclophosphamide dosing in older or unfit pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Influenza Vaccination Strategy for Patients With Hematologic Malignancy [Phase 3]
A Phase 3 clinical trial update evaluating an influenza vaccination strategy in patients with hematologic neoplasms; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) [Phase 1]
This clinical trial update describes a Phase 1 study of AZD2962, an IRAK4 inhibitor, in participants with hematologic neoplasms, currently r…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating donor lymphocyte infusion after allogeneic hematopoietic cell transplantation in patients with high…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation [Phase 1]
A Phase I trial is evaluating the integration of HLA-haploidentical anti-CD19 CAR-T cells with post-transplant cyclophosphamide-based haploi…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating bendamustine with or without cyclophosphamide to prevent graft-versus-host disease in patients undergo…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation to prevent acute graft-versus-host disease in adults undergoing allogenei…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) [Phase 3]
The PATH III trial is a Phase 3 study evaluating platelet transfusions in hematopoietic stem cell transplantation and is currently recruitin…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion [NA]
Clinical trial comparing the Hemanext ONE System to conventional red blood cell transfusion; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Optimizing PTCy Dose and Timing [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 study aiming to optimize the dose and timing of post-transplant cyclophosphamide t…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial is evaluating ibrutinib for prevention of chronic graft-versus-host disease in patients receiving donor stem cell t…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil [Phase 2]
Phase 2 trial evaluating fludarabine with total body irradiation and post-transplant cyclophosphamide/tacrolimus GVHD prophylaxis (without m…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 4]
Phase 4 clinical trial update indicating Gardasil 9 is being studied to prevent HPV infection in patients with hematologic malignancies unde…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Multi-center Investigation of Family Health.
Odense University Hospital is sponsoring a multi-center study on family health that is currently recruiting, with focus conditions including…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash [NA]
An update on a clinical trial evaluating a protective oral care protocol using peppermint oil mouthwash for patients with hematologic neopla…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Increasing Knowledge and Interest in Cancer Clinical Trials [NA]
This is a recruiting clinical trial listing sponsored by Hayley Thompson, investigating hematologic neoplasms and malignant solid neoplasms.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation [NA]
This document reports that the NCT04691284 trial on the microbiome in cancer patients undergoing high-dose chemotherapy with stem cell trans…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms
A ClinicalTrials.gov entry describes The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms, a recruiting study le…
-
CLINICAL_TRIALS research · 2017-10-25Clinical Trial Update: Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT [Phase 2]
This Phase 2 clinical trial update investigates the efficacy and safety of high-dose vitamin D supplementation in patients undergoing hemato…
-
CLINICAL_TRIALS research · 2013-05-31Clinical Trial Update: Biomarker Research for Personalized Medicine
This clinical trial update describes biomarker research for personalized medicine in hematologic neoplasms, sponsored by Inje University, wi…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation
This clinical trial update summarizes patient symptom experiences and self-management after hematopoietic stem cell transplantation in hemat…